In addition, fluorescent CBA is based on an easy and standardized technique, that is already used by many laboratories to identify antibodies to central nervous system antigens, such as antibodies to neuronal surface antigens in patients with autoimmune encephalitis or to aquaporin-4 in subjects with neuromyelitis optica spectrum disorders (17). This evidence concerns the gene AQP4 and neuromyelitis optica.